Table 2.
Summary of serological markers for HBV infection in HIV-positive and HIV-negative groups
| Infection | Serological markers | HIV-positive group (N = 133) | HIV-negative group (N = 133) | Statistical significance* | ||||
|---|---|---|---|---|---|---|---|---|
| HBsAg | HBcAb | HBsAb | No. of cases | (%) | No. of cases | (%) | ||
| Positive | 84 | (63·2) | 34 | (25·6) | P <0·001 | |||
| Present | + | − | − | 3 | (2·3) | 0 | (0) | n.s. |
 |
+ | + | − | 12 | (9) | 2 | (1·5) | P <0·05 |
| − | + | − | 27 | (20·3) | 9 | (6·8) | P <0·01 | |
| − | + | + | 35 | (26·3) | 17 | (12·8) | P <0·01 | |
| − | n.t. | + | 1 | (0·8) | 0 | (0) | n.s. | |
| Past | − | − | + | 6 | (4·5) | 6 | (4·5) | n.s. |
| Negative | − | − | − | 49 | (36·8) | 99 | (74·4) | P <0·001 |
n.s., Not significant; n.t., not tested.
*
χ2 test between HIV-positive and HIV-negative groups.